Story · Medicine & Biotech
Aspirin does not reduce risks for major CV events vs. usual care in CKD
1 outlet · first reported by Healio 14d ago
Coverage, in order
-
14d ago
Aspirin does not reduce risks for major CV events vs. usual care in CKDDENVER — Low-dose aspirin did not significantly reduce risks for major CV events vs. usual care among patients with chronic kidney disease, according to data presented at ASN Kidney Week. “We’re not in a place where we should be offering aspirin for primary prevention at this stage,” Hugh…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.